Frequently asked questions about parallel distribution

Veterinary medicines European public assessment report (EPAR): Zulvac 1+8 Ovis, inactivated bluetongue serotype 1+8 vaccine, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Zulvac 1+8 Bovis, inactivated bluetongue virus, serotypes 1 and 8, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Zulvac 8 Ovis, inactivated bluetongue virus, serotype 8, Status: Authorised

Veterinary medicines European public assessment report (EPAR): VarroMed, oxalic acid dihydrate / formic acid, Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Veltassa, patiromer sorbitex calcium, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Metabolism and nutrition disorders, PIP number: P/0313/2024

Veterinary medicines European public assessment report (EPAR): UpCard, torasemide, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Ultifend ND IBD, Newcastle disease,infectious bursal disease,Marek's disease vaccine (live recombinant), Status: Authorised

Opinion/decision on a Paediatric investigation plan (PIP): Mylotarg, gemtuzumab ozogamicin, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps), PIP number: P/0314/2024

Opinion/decision on a Paediatric investigation plan (PIP): Ervebo, Ebola Zaire Vaccine (rVSV∆G-ZEBOV-GP, live), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0315/2024